BDX · News · 20260806N
Guidance / Outlook
BECTON DICKINSON & CO · 2026-08-06 · Importance 51 · Surprise 60 · In source text
BD raised its fiscal 2026 adjusted diluted EPS guidance midpoint to $12.67 and expects revenue growth toward the high end of its previously stated range. Third-party reporting attributed the improved outlook to stronger demand for drug-delivery devices, surgical equipment, and other growth platforms. Management also expects to offset potential cost increases from volatile oil prices affecting resin and molded plastics through pricing actions.
Key facts
- Following Q3 results, the company raised its full-year fiscal 2026 adjusted diluted EPS guidance midpoint to $12.67. source
- Company projects fiscal 2026 adjusted EPS to be between $12.62 and $12.72 for the year. source
- Company updated full-year guidance, expects revenue growth toward the high end of its range and raised the midpoint of adjusted diluted EPS guidance. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | probable | — | Company projects fiscal 2026 adjusted EPS to be between $12.62 and $12.72 for the year. |
| revenue | positive | probable | — | Company updated full-year guidance, expects revenue growth toward the high end of its range and raised the midpoint of adjusted diluted… |